Your browser doesn't support javascript.
loading
Current and future challenges in quality assurance in molecular diagnostics.
Ahmad-Nejad, Parviz; Ashavaid, Tester; Vacaflores Salinas, Aldo; Huggett, Jim; Harris, Kathryn; Linder, Mark W; Baluchova, Katarina; Steimer, Werner; Payne, Deborah A.
Afiliación
  • Ahmad-Nejad P; Institute for Medicine Laboratory Diagnostics, Centre for Clinical and Translational Research (CCTR), HELIOS University Hospital, Wuppertal, Witten/Herdecke University, Germany. Electronic address: parviz.ahmad-nejad@helios-gesundheit.de.
  • Ashavaid T; Department of Laboratory Medicine, P.D. Hinduja National Hospital and Medical Research Center, Mumbai, India.
  • Vacaflores Salinas A; Plexus Laboratorio, La Paz, Bolivia.
  • Huggett J; National Measurement Laboratory (NML) at LGC, Queens Rd, Teddington, TW11 0LY, United Kingdom; School of Biosciences & Medicine, Faculty of Health & Medical Science, University of Surrey, Guildford GU2 7XH, United Kingdom.
  • Harris K; Microbiology Department, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
  • Linder MW; Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine, Louisville, KY, USA.
  • Baluchova K; OncoLab Diagnostics GmbH Technologie- und Forschungszentrum, Viktor-Kaplan-Straße 2, 2700 Wiener Neustadt, Austria.
  • Steimer W; Institute for Clinical Chemistry and Pathobiochemistry, Munich University of Technology, Klinikum rechts der Isar, D-81675 Munich, Germany.
  • Payne DA; CPDP Consulting, LLC, Denver, CO, USA.
Clin Chim Acta ; 519: 239-246, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33971158
The development and performance of molecular genetic assays has required increasingly complex quality assurance in recent years and continues to pose new challenges. Quality management officers, as well as academic and technical personnel are confronted with new molecular genetic parameters, methods, changing regulatory environments, questions regarding appropriate validation, and quality control for these innovative assays that are increasingly applying quantification and/or multiplex formats. Yet, quality assurance and quality control guidelines are still not widely available or in some circumstances have become outdated. For these reasons, the need for solutions to provide test confidence continues to grow. In order to integrate new test procedures into existing quality assurance measures, the ISO 15189 guideline can serve as an orientation. The ISO 15189 guideline describes requirements for medical laboratories and thus includes those performing molecular diagnostics. This article gives an overview of the possibilities and challenges in quality assurance of molecular parameters and shows possible solutions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Patología Molecular / Laboratorios Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Chim Acta Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Patología Molecular / Laboratorios Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Clin Chim Acta Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos